Clinical Effects of Translatoric Grades of Movement in Hip Osteoarthritis Patients
2 other identifiers
interventional
60
1 country
1
Brief Summary
In orthopaedic manual therapy translatoric grades of movement are used to determine the intensity of force applied during the mobilization. Different clinical effects are described for each translatoric grade of movement but there are not published studies evaluating these clinical effects. The objective of this trial is to determine if force magnitude during hip traction in resting position affects immediate and short-term outcomes (pain, physical function, hip muscle length and hip range of motion) in patients with hip osteoarthritis. For this purpose, investigators conduct a randomized clinical trial, double-blind (patient and physical therapist examiner). Participants entering the study were randomized into 1 of 3 treatment groups: grade I- grade IISZ mobilization, grade IITZ mobilization or grade III mobilization. Participants attend three sessions on alternate days (monday, wednesday, friday) and at the same hour. Measurements are taken prior to treatment, immediately after each session treatment. The participants are recruited from physiotherapy groups or referred by general practitioners and orthopedic surgeons. Participants were assigned to 1 of the 3 study groups through concealed allocation (sealed envelopes) and independent blocked randomization, using a random number generator. One physical therapist enroll patients in the study, while an independent research assistant performed the randomization and prepared the sealed envelopes, which are opened after baseline data collection by the physiotherapist performing the treatments. Participants are treated in a private treatment area and have no knowledge of treatments received by other participants. A second experienced orthopaedic manual therapist applies the standardized hip traction mobilization in resting position at either level of force, during 10 minutes. This amount of mobilization is consistent with clinical practice and previous studies in osteoarthritis patients. Two physiotherapists (third and fourth) with 5 years of experience, who were blinded to participant group, performed all measurements.The outcome measures are pain, physical function, hip muscle length and hip passive range of motion. Pain is registered with visual analogic scale (VAS), Pressure Pain Threshold ( PPT) and WOMAC pain subscale. Physical function is registered using Timed Up \& Go test (TUG), the 20-Meter Walking Test (20MWT) and the physical function subscale of WOMAC index. The hip muscle length is measured using Ely´s test, Active Knee Extension test and modified Ober´s test. The passive hip range of motion is measured using inclinometer or goniometer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2015
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2015
CompletedFirst Submitted
Initial submission to the registry
July 8, 2015
CompletedFirst Posted
Study publicly available on registry
July 15, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedJuly 2, 2017
June 1, 2017
8 months
July 8, 2015
June 29, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Pain on the VAS scale
pre-intervention and post-intervention (baseline and 5 days)
Pressure Pain Threshold (PPT)
pre-intervention and post-intervention (baseline and 5 days)
Pain on the pain subscale of WOMAC index (WOMAC-P)
pre-intervention and the next day of the last treatment session (baseline and 6 days)
Secondary Outcomes (7)
Physical Function on Timed Up & Go test (TUG)
pre-intervention and post-intervention (baseline and 5 days)
Physical Function on the 20-Meter Walking Test
pre-intervention and post-intervention (baseline and 5 days)
Physical Function on The physical function subscale of WOMAC index (WOMAC-PF)
pre-intervention and the next day of the last treatment session (baseline and 6 days)
Hip range of motion with digital inclinometer
pre-intervention and post-intervention (baseline and 5 days)
Rectus femoris flexibility assessment: Ely´s test
pre-intervention and post-intervention (baseline and 5 days)
- +2 more secondary outcomes
Study Arms (3)
Grade I-II SZ mobilization
EXPERIMENTALGrade I-IISZ hip traction in resting position
Grade II TZ mobilization
EXPERIMENTALGrade IITZ hip traction in resting position
Grade III mobilization
EXPERIMENTALGrade III hip traction in resting position
Interventions
Hip grade I-IISZ traction in a resting position is applied using gentle repetitive traction movements during 10 minutes. The mean peak force applied is 2,71N (S.D= 0,94), according to previous study. Peak forces were measured using dynamometer and the therapist used it as a feedback to ensure mean peak force levels remain consistent.
Hip grade IITZ traction in a resting position is applied during 10 minutes. The traction force is applied during 45 seconds with 15 seconds rest, until complete the 10 minutes of treatment. The mean peak force applied is 5.94 N (S.D= 1), according to previous study. Peak forces were measured using dynamometer and the therapist used it as a feedback to ensure mean peak force levels remain consistent.
Hip grade III traction in a resting position is applied during 10 minutes. The traction force is applied during 30 seconds with 30 seconds rest, until complete the 10 minutes of treatment. The mean peak force applied is 7.04 N (S.D= 0.32), according to previous study. Peak forces were measured using dynamometer and the therapist used it as a feedback to ensure mean peak force levels remain consistent.
Eligibility Criteria
You may qualify if:
- unilateral primary hip OA according to the clinical criteria of the American College of Reumathology,
- a grade III Kellgren \& Lawrence (K-L) classification in their most recent hip X-rays,
- mild to moderate pain from hip OA categorized using the WOMAC pain subscale (2 to 8 as mild pain; greater than 8 to 12 as moderate pain),
- the ability to walk at least 20 meters, with or without an aid.
You may not qualify if:
- neurological, vascular or other lower extremity musculoskeletal conditions that affected sensation, gait or functional performance,
- contraindications for manual therapy
- insufficient understanding of the Spanish language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Elena Estebanez de Miguel
Zaragoza, 50009, Spain
Related Publications (1)
Estebanez-de-Miguel E, Fortun-Agud M, Jimenez-Del-Barrio S, Caudevilla-Polo S, Bueno-Gracia E, Tricas-Moreno JM. Comparison of high, medium and low mobilization forces for increasing range of motion in patients with hip osteoarthritis: A randomized controlled trial. Musculoskelet Sci Pract. 2018 Aug;36:81-86. doi: 10.1016/j.msksp.2018.05.004. Epub 2018 May 29.
PMID: 29864710DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elena Estebanez, PhD
Unidad de Investigación en Fisioterapia. Zaragoza, Zaragoza, Spain
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Unidad de investigación en Fisioterapia
Study Record Dates
First Submitted
July 8, 2015
First Posted
July 15, 2015
Study Start
April 1, 2015
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
July 2, 2017
Record last verified: 2017-06